Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of FPA008 in healthy volunteers and rheumatoid arthritis subjects
NL-OMON40412Phase 1Active, not recruiting
- Sponsor
- Five Prime Therapeutics, Inc.
- Start
- Oct 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in rheumatoid arthritis (RA) comparing FPA008 with Placebo (2 arms). Started Oct 2013; status: active, not recruiting.
02
Drugs
cabiralizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON40412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40412.